Format

Send to

Choose Destination
Trends Mol Med. 2003 Apr;9(4):169-76.

Protein carbonylation in human diseases.

Author information

1
Department of Biology, University of Milan, via Celoria 26, I-20133 Milan, Italy. quack@mailserver.unimi.it

Abstract

Oxidative modifications of enzymes and structural proteins play a significant role in the aetiology and/or progression of several human diseases. Protein carbonyl content is the most general and well-used biomarker of severe oxidative protein damage. Human diseases associated with protein carbonylation include Alzheimer's disease, chronic lung disease, chronic renal failure, diabetes and sepsis. Rapid recent progress in the identification of carbonylated proteins should provide new diagnostic (possibly pre-symptomatic) biomarkers for oxidative damage, and yield basic information to aid the establishment an efficacious antioxidant therapy.

PMID:
12727143
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center